← Eichor
Condition: Neuromuscular Blocking Agents Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Neuromuscular Blocking Agents

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Comparison of an Acceleromyography- and Electromyography-based Neuromuscular Monitor With TOF-Watch ® Monitor
Phase N/A · 2 location(s) · Huazhong University of Science and Technology · NCT05632107
Incidence of Residual Neuromuscular Blockade in Fraility in OncoGynae Surgery
NA · 1 location(s) · Mahidol University · NCT06216002
GERAP's Epidemiological Survey on Perioperative Hypersensitivity Reactions
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT04654923
Median Nerve Electromyography to Monitor Intraoperative Neuromuscular Function
Phase N/A · 1 location(s) · Pongrácz Adrienn · NCT07571395
Pharmacological Reversal of Neuromuscular Blockade in Critically Ill Patients
NA · 1 location(s) · Seoul National University Hospital · NCT05993390
Recovery Times of Half Dose Sugammadex and Neostigmine for Rocuronium-induced Neuromuscular Blockade
Phase 1/Phase 2 · 1 location(s) · Universitas Padjadjaran · NCT06794450
High Dimensional Analysis of Immune Cells in Pediatric Patients
Phase N/A · 1 location(s) · Seoul National University Hospital · NCT05820802
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.